Granahan Investment Management REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 164 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Granahan Investment Management ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$3,091
-2.0%
223,631
+38.3%
0.11%
+35.9%
Q1 2022$3,153
-10.8%
161,695
-25.3%
0.08%
+6.8%
Q4 2021$3,533
-1.1%
216,497
+68.8%
0.07%
+7.4%
Q3 2021$3,573128,2390.07%